|
Volumn 31, Issue 1, 2009, Pages 150-157
|
Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
GAMMA INTERFERON;
GANGLIOSIDE GM1;
GANGLIOTETRAOSYLCERAMIDE;
INTERLEUKIN DERIVATIVE;
LEUKOCYTE ANTIGEN;
LIPOPOLYSACCHARIDE;
MONOCLONAL ANTIBODY;
PROPOFOL;
TUMOR ANTIGEN;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
C57BL MOUSE;
CELL DIFFERENTIATION;
CYTOLOGY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY TEST;
DENDRITIC CELL;
DRUG EFFECT;
EXPERIMENTAL MELANOMA;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE DEPLETION;
MALE;
METABOLISM;
MIXED LYMPHOCYTE CULTURE;
MOUSE;
NATURAL KILLER CELL;
T LYMPHOCYTE;
TH1 CELL;
TH2 CELL;
TRANSPLANTATION;
TUMOR CELL LINE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
CELL DIFFERENTIATION;
CELL LINE, TUMOR;
CYTOTOXICITY TESTS, IMMUNOLOGIC;
DENDRITIC CELLS;
G(M1) GANGLIOSIDE;
INTERFERON-GAMMA;
INTERLEUKINS;
KILLER CELLS, NATURAL;
LIPOPOLYSACCHARIDES;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE CULTURE TEST, MIXED;
LYMPHOCYTE DEPLETION;
MALE;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
PROPOFOL;
T-LYMPHOCYTES;
T-LYMPHOCYTES, CYTOTOXIC;
TH1 CELLS;
TH2 CELLS;
|
EID: 77449107389
PISSN: None
EISSN: 15322513
Source Type: Journal
DOI: 10.1080/08923970802590415 Document Type: Article |
Times cited : (11)
|
References (0)
|